HealthDay News — A quadrivalent nucleoside-modified messenger RNA (modRNA) influenza vaccine is superior to a licensed inactivated quadrivalent influenza vaccine, according to a study published in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback